193 related articles for article (PubMed ID: 10983692)
1. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
Lee KB; Kim UK; Lee CC
J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692
[TBL] [Abstract][Full Text] [Related]
2. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease.
Pérez-Oller L; Torra R; Badenas C; Milà M; Darnell A
Am J Kidney Dis; 1999 Aug; 34(2):273-8. PubMed ID: 10430974
[TBL] [Abstract][Full Text] [Related]
3. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
[TBL] [Abstract][Full Text] [Related]
4. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
[TBL] [Abstract][Full Text] [Related]
5. Influence of angiotensin converting enzyme (
Ramanathan G; Ghosh S; Elumalai R; Periyasamy S; Lakkakula BV
Indian J Med Res; 2016 Jun; 143(6):748-755. PubMed ID: 27748299
[TBL] [Abstract][Full Text] [Related]
6. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease.
Baboolal K; Ravine D; Daniels J; Williams N; Holmans P; Coles GA; Williams JD
Kidney Int; 1997 Sep; 52(3):607-13. PubMed ID: 9291178
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of ACE DD genotype among north Indian end stage renal disease patients.
Tripathi G; Dharmani P; Khan F; Sharma RK; Pandirikkal V; Agrawal S
BMC Nephrol; 2006 Oct; 7():15. PubMed ID: 17042963
[TBL] [Abstract][Full Text] [Related]
8. The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease.
van Dijk MA; Breuning MH; Peters DJ; Chang PC
Nephrol Dial Transplant; 2000 Jun; 15(6):836-9. PubMed ID: 10831637
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease.
Schiavello T; Burke V; Bogdanova N; Jasik P; Melsom S; Boudville N; Robertson K; Angelicheva D; Dworniczak B; Lemmens M; Horst J; Todorov V; Dimitrakov D; Sulowicz W; Krasniak A; Stompor T; Beilin L; Hallmayer J; Kalaydjieva L; Thomas M
Nephrol Dial Transplant; 2001 Dec; 16(12):2323-7. PubMed ID: 11733623
[TBL] [Abstract][Full Text] [Related]
10. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD.
Lee KB; Kim UK
Yonsei Med J; 2003 Aug; 44(4):641-7. PubMed ID: 12950120
[TBL] [Abstract][Full Text] [Related]
11. ACE gene I/D polymorphism and the presence of renal failure or hypertension in autosomal dominant polycystic kidney disease (ADPKD).
Gumprecht J; Zychma MJ; Karasek D; Grzeszczak W
Nephrol Dial Transplant; 2007 May; 22(5):1483. PubMed ID: 17205958
[No Abstract] [Full Text] [Related]
12. Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease.
Uemasu J; Nakaoka A; Kawasaki H; Ishikawa I; Yoshino Y; Shio H; Nemoto R; Nakamura I; Morio S
Life Sci; 1997; 60(23):2139-44. PubMed ID: 9180368
[TBL] [Abstract][Full Text] [Related]
13. No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease.
Ecder T; McFann KK; Raynolds MV; Schrier RW
Am J Nephrol; 2003; 23(6):466-70. PubMed ID: 14600431
[TBL] [Abstract][Full Text] [Related]
14. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease.
Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B
Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132
[TBL] [Abstract][Full Text] [Related]
15. Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease.
Merta M; Reiterová J; Stekrová J; Rysava R; Rihová Z; Tesar V; Viklický O; Kmentova D
Kidney Blood Press Res; 2003; 26(1):42-9. PubMed ID: 12697976
[TBL] [Abstract][Full Text] [Related]
16. The influence of the endothelin-converting enzyme-1 gene polymorphism on the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Stekrová J; Tesar V; Kmentová D; Ríhová Z; Rysavá R; Viklický O
Ren Fail; 2006; 28(1):21-4. PubMed ID: 16526315
[TBL] [Abstract][Full Text] [Related]
17. Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan.
Konoshita T; Miyagi K; Onoe T; Katano K; Mutoh H; Nomura H; Koni I; Miyamori I; Mabuchi H
Am J Kidney Dis; 2001 Jan; 37(1):113-118. PubMed ID: 11136175
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
[TBL] [Abstract][Full Text] [Related]
19. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
[TBL] [Abstract][Full Text] [Related]
20. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
Zivko M; Kusec R; Galesić K
Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
